Facilty Design & Management Page
Once biopharma companies optimize operations in order to free up hidden capacity, they have four options: build, acquire, partner or face the realities of outsourcing
Hyderabad-based API provider Neuland Labs sheds the stigma of Indian manufacturers by building stringent quality control into every process
iBio’s commercial-scale biotherapeutics manufacturing facility built speed and flexibility into every step – from initial design and construction to daily operations
Corrective actions are implemented to reduce future failures, but resources aren’t allocated to identify the root cause on a significant failure; This gap creates the opportunity to implement a RCFA program.
White Papers: In Depth Research
Posted: Nov 17, 2016
Pharma’s leaders continue to pursue success through a strategy of careful capital expenditure investment with an eye on increased capacity, speed and efficiency in their facilities.
Posted: Nov 11, 2015
Pharma’s operational excellence is being fueled by increased capital spending.
Posted: Jun 17, 2015
A paradigm shift in flexible biopharmaceutical production sites and process designs is underway and requires capacity utilization and process flexibility.
Posted: Feb 20, 2015
The pharmaceutical manufacturing landscape has changed notably over the past decade and is continuing to evolve rapidly. Pharmaceutical manufacturers have begun to wield some new tools, nailing down new efficiencies and better drugs in the process.